Identification of warning transition points from hepatitis b to hepatocellular carcinoma based on mutation accumulation for the early diagnosis and potential drug treatment of hbv-hcc

HIGHLIGHTS

• who: Fei Xu et al. from the Department of Pharmacogenomics, College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China have published the research: Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC, in the Journal: Oxidative Medicine and Cellular Longevity 1.0 of 25/07/2022
• what: The authors got the mutation cluster as a new research unit using the Random Walks with Restarts algorithm that is used to describe the efficient boundary of mutation influences . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.